Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Innovalve acquisition will strengthen Edwards Lifesciences’ transcatheter valve replacement segment, says GlobalData

Edwards Lifesciences recently announced the completion of the $300 million acquisition of Innovalve Bio Medical, which specializes in transcatheter heart valve devices. The deal follows an initial investment by Edwards Lifesciences in Innovalve’s transcatheter mitral valve replacement (TMVR) research. Innovalve’s Innostay device recently received FDA approval to begin limited clinical trials in the US, with […]
Read more

Hematology analyzers market in Japan to grow at 5% CAGR through 2033, forecasts GlobalData

Japan’s high-tech healthcare system relies heavily on hematology analyzers, which automate blood analysis that translates to faster diagnoses and targeted treatment for a wide range of blood conditions. Against this backdrop, Japan’s hematology analyzers market is expected to grow at a compound annual growth rate (CAGR) of around 5% through 2033, forecasts GlobalData, a leading […]
Read more

Roche’s AI CGM solution poised to revolutionize diabetes management with CE marking, says GlobalData

Roche recently announced that its artificial intelligence (AI)-enabled continuous glucose monitoring (CGM) solution received the CE mark, signaling a significant advancement in diabetes management. With the CE mark, Roche’s innovative solution is poised to revolutionize diabetes management and enhance patient care, says GlobalData, a leading data and analytics company. According to GlobalData, the AI market […]
Read more

Roche’s foray into continuous glucose monitors dependent on AI efficacy, says GlobalData

Roche’s artificial intelligence (AI)-enabled continuous glucose monitoring system has gained Conformité Européenne (CE) marking. If this AI tool can accurately predict glucose levels, this new tool has the potential to provide diabetic patients with a greater degree of control and prevent dangerous hypo- and hyperglycemic events. However, the system’s success hinges on the accuracy and […]
Read more

AI revolutionizing more areas of medical than ever before, says GlobalData

Artificial Intelligence (AI) has emerged as a transformative force across various sectors, and healthcare is no exception. It is continually revolutionizing healthcare and can contribute to cost reduction and efficiency improvement in several ways. Within the realm of medical devices, AI is driving significant advancements, improving diagnostic accuracy, personalizing treatments, and enhancing patient outcomes. The […]
Read more

South Korea radiosurgery systems market to see 6% CAGR through 2033, forecasts GlobalData

Brain tumors and associated neurological disorders pose a serious medical issue, impacting millions of people worldwide. These tumors interfere with normal brain activity, resulting in a range of symptoms such as headaches, seizures, and cognitive decline. This has driven the demand for advanced, minimally invasive treatments. In this context, South Korea’s radiosurgery systems market is […]
Read more

Precision medicine transforms healthcare beyond oncology, says GlobalData

Precision medicine is reshaping healthcare beyond its traditional focus on oncology. This innovative approach tailors medical treatments to individual genetic, environmental, and lifestyle factors, enhancing disease prevention, diagnosis, and treatment efficacy. From reproductive health advancements like biomarker screenings in IVF to pandemic preparedness initiatives, precision medicine is expanding its impact across diverse medical fields, promising […]
Read more

Boston Scientific’s DBS software signals positive shift in Parkinson’s disease treatment with CE marking, says GlobalData

Boston Scientific recently secured the European CE marking of its Vercise Neural Navigator 5 Software, a key component of the company’s Deep Brain Stimulation (DBS) system for Parkinson’s disease treatment. The rapid expansion and innovation in digital health technologies, coupled with developments like Boston Scientific’s new DBS system, signals a positive shift in patient care. […]
Read more

Companion diagnostics drive precision oncology growth and accessibility, says GlobalData

Companion diagnostic (CDx) tests play a pivotal role in modern oncology by identifying specific biomarkers that guide personalized cancer treatments. These tests, such as HER2 testing in breast cancer, determine eligibility for targeted therapies like trastuzumab. The evolving landscape of CDx tests is marked by decreasing costs, driven by technological advancements and economies of scale, […]
Read more

Direct-to-watch integration to strengthen Dexcom’s position in wearable health technology, says GlobalData

The COVID-19 pandemic has acted as a catalyst for the rapid implementation and development of wearable technology in the medical market. Wearable technologies, such as smartwatches and medical-grade wearables, have emerged as indispensable tools for remotely tracking glucose levels and managing diabetes. Following the wearable trend in medical, the recent update enables Apple Watch users […]
Read more

Rising diabetes rates and technology advancements to drive diabetes device market growth, says GlobalData

The global market for continuous glucose monitors (CGMs) is poised for rapid growth, driven by the increasing prevalence of diabetes and advancements in medical technology. The International Diabetes Federation (IDF) forecasts that the global diabetes population will reach 643 million by 2030, with North America experiencing significant increases. This increase in diabetes rates, coupled with […]
Read more

Microbot Medical and Boston Hospital collaboration holds potential to transform robotic surgeries, says GlobalData

Medical technology company Microbot Medical recently announced a strategic partnership with a prominent Boston Hospital to conduct clinical trials of its revolutionary Liberty Surgical Robot. The partnership signifies a major advancement in the field of surgical robotics. By leveraging advanced technology, this collaboration holds the potential to redefine surgical precision and patient outcomes, setting a […]
Read more

TAVR treatment remains low in bicuspid aortic valve stenosis patients, finds GlobalData

Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic valve stenosis (AS), providing a less invasive alternative to traditional surgical aortic valve replacement (SAVR). Initially approved for high-risk surgical patients, TAVR’s indications have expanded to include intermediate and even low-risk patients. However, its application in patients with bicuspid aortic valve (BAV) disease presents […]
Read more
1 … 11 12 13 14 15 … 50